SCI Pharmtech, Inc. (TPE: 4119)
Taiwan
· Delayed Price · Currency is TWD 91.00
-0.40 (-0.44%)
Oct 11, 2024, 1:30 PM CST
SCI Pharmtech Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 10, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 10,816 | 11,568 | 9,300 | 8,012 | 6,677 | 8,454 | Upgrade
|
| Market Cap Growth | -4.42% | 24.39% | 16.07% | 20.00% | -21.02% | 50.44% | Upgrade
|
| Enterprise Value | 11,033 | 12,218 | 9,171 | 6,991 | 6,202 | 7,629 | Upgrade
|
| Last Close Price | 90.50 | 95.46 | 83.96 | 72.33 | 59.95 | 74.41 | Upgrade
|
| PE Ratio | 75.89 | 35.49 | 29.25 | 140.29 | 17.99 | 14.11 | Upgrade
|
| PS Ratio | 8.34 | 9.61 | 10.34 | 9.27 | 2.48 | 3.59 | Upgrade
|
| PB Ratio | 2.14 | 2.27 | 2.56 | 2.41 | 2.01 | 2.43 | Upgrade
|
| P/FCF Ratio | -13.65 | -14.22 | -10.68 | -16.33 | 8.86 | 14.28 | Upgrade
|
| P/OCF Ratio | 102.39 | 53.62 | 31.36 | 28.59 | 6.87 | 10.68 | Upgrade
|
| EV/Sales Ratio | 8.81 | 10.15 | 10.19 | 8.09 | 2.31 | 3.24 | Upgrade
|
| EV/EBITDA Ratio | 34.69 | 40.23 | 44.10 | 51.56 | 5.24 | 9.17 | Upgrade
|
| EV/EBIT Ratio | 87.49 | 76.22 | 77.09 | 94.91 | 5.90 | 10.94 | Upgrade
|
| EV/FCF Ratio | -13.94 | -15.02 | -10.53 | -14.25 | 8.23 | 12.89 | Upgrade
|
| Debt / Equity Ratio | 0.22 | 0.20 | 0.15 | 0.00 | 0.00 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 3.35 | 3.41 | 2.60 | 0.02 | 0.00 | 0.00 | Upgrade
|
| Debt / FCF Ratio | -1.43 | -1.28 | -0.63 | 0.00 | 0.00 | 0.01 | Upgrade
|
| Asset Turnover | 0.20 | 0.21 | 0.20 | 0.20 | 0.62 | 0.60 | Upgrade
|
| Inventory Turnover | 1.61 | 1.64 | 1.51 | 1.94 | 3.12 | 2.76 | Upgrade
|
| Quick Ratio | 1.65 | 2.35 | 0.61 | 1.39 | 1.33 | 2.35 | Upgrade
|
| Current Ratio | 2.59 | 3.43 | 1.35 | 1.87 | 1.71 | 3.31 | Upgrade
|
| Return on Equity (ROE) | 3.02% | 6.75% | 8.89% | 1.68% | 10.60% | 17.09% | Upgrade
|
| Return on Assets (ROA) | 1.48% | 1.72% | 1.63% | 1.05% | 15.19% | 11.07% | Upgrade
|
| Return on Capital (ROIC) | 1.65% | 1.94% | 1.98% | 1.39% | 19.32% | 13.03% | Upgrade
|
| Earnings Yield | 1.32% | 2.55% | 3.32% | 0.70% | 5.39% | 6.76% | Upgrade
|
| FCF Yield | -7.32% | -7.03% | -9.37% | -6.13% | 11.29% | 7.00% | Upgrade
|
| Dividend Yield | 1.37% | 1.31% | 0.26% | - | 0.62% | 5.77% | Upgrade
|
| Payout Ratio | 17.22% | 8.09% | - | 71.36% | 128.02% | 58.46% | Upgrade
|
| Buyback Yield / Dilution | -7.55% | -1.87% | -0.08% | 0.49% | 0.26% | 0.07% | Upgrade
|
| Total Shareholder Return | -6.18% | -0.56% | 0.19% | 0.49% | 0.87% | 5.84% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.